Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia Ana Paula Schonardie; Eduarda Beck; Maria Helena Rigatto;

Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia Jessica Matuoka; Daniela Vianna Pachito; Filipe Piastrelli; Lorena Cristina Correa Fehlberg; Haliton Alves de Oliveira Junior;

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015¿2020 Mark G. Wise; James A. Karlowsky; Elkin V. Lemos-Luengas; Rafael R. Valdez; Daniel F. Sahm;